CLINICAL_TRIALS
trial_result
· 2026-03-24
Clinical Trial Update: A Long-Term Safety and Efficacy Study of Lorecivivint in Subjects With Osteoarthritis of the Knee [Phase 3]
Summary
Phase 3 long-term safety and efficacy study of lorecivivint in osteoarthritis of the knee has been terminated with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Biosplice Therapeutics, Inc. | Conditions: Osteoarthritis, Knee | Phase 3 | Status: TERMINATED | Results posted: 2026-03-24